SCHEMBL2837016

SCHEMBL2837016

CN1CCC(Oc2cccc(Cl)c2Cl)c2ccsc2C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 1/20 0.38
DRD2 P14416 3/20 0.37
DRD3 P35462 1/20 0.37
HTR1D P28221 2/20 0.36
HTR1B P28222 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
SIGMAR1 Q99720 1/20 0.35
ALDH1A1 P00352 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GAA P10253 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
MAPK1 P28482 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KMT2A Q03164 1/20 0.35
HHAT Q5VTY9 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2879094 0.99 DRD1 (0.38) DRD1DRD2DRD3HTR1DHTR1B
SCHEMBL2840634 0.89 NPC1 (0.39) DRD1DRD2DRD3HTR1DHTR1B
SCHEMBL2840963 0.84 SIGMAR1 (0.35) DRD1DRD2DRD3HTR1DHTR1B
Hydrochloric Acid SCHEMBL2840393 0.83 SIGMAR1 (0.35) DRD1DRD2DRD3HTR1DHTR1B
Hydrochloric Acid SCHEMBL2839630 0.80 MEN1 (0.42) NPC1RAB9AL3MBTL1KMT2AHHAT
SCHEMBL2836900 0.79 ALDH1A1 (0.34) DRD1DRD2DRD3HTR1DHTR1B
Hydrochloric Acid SCHEMBL2837012 0.78 ALDH1A1 (0.38) DRD1DRD2SIGMAR1ALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL2835500 0.78 ALDH1A1 (0.33) DRD1DRD2DRD3HTR1DHTR1B
SCHEMBL2841045 0.77 ALDH1A1 (0.34) DRD1DRD2DRD3HTR1DHTR1B
Hydrochloric Acid SCHEMBL2840470 0.76 GPBAR1 (0.33) DRD1DRD2DRD3HTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US claimed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP claimed
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 DRD1 40/4885DRD2 58/4885DRD3 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.